Table 2.

Change in body weight in patients treated with tolvaptan for liver cirrhosis and edema, stratified by subgroups

	N	Mean ± SD	Median	P valuea
Hepatocellular carcinoma
Yes	288	− 3.21 ± 4.93	− 2.70	0.2248
No	413	− 3.70 ± 5.53	− 3.20
Albumin (g/dL)
< 2.5	209	− 3.85 ± 5.47	− 3.40	0.3372
≥ 2.5	365	− 3.42 ± 5.11	− 2.80
Serum Na (mEq/L)
< 125	13	− 5.25 ± 6.86	− 3.40	0.2222
≥ 125	684	− 3.45 ± 5.25	− 2.90

SD standard deviation

^aStudent’s t test

^*< 0.05

**< 0.01

***< 0.001